Vinit Bolinjkar on what’s leading to uptick in Reliance Industries
Vinit Bolinjkar, Head of Research at Ventura Securities, cautions against investing in Paytm due to RBI's strong guidance and the company's history of violations and penalties. Positive news on Jio and retail divestment may support Reliance Industries' growth. Marksans Pharma is recommended as a good long-term investment. Marksans is a very good name to be long in, says Bolinjkar
Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.
